Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24285844 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
HerpeVac Trial for Young Women
Condition: Herpes Simplex Infection
Interventions: Biological: HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine;   Biological: Havrix™, GlaxoSmithKline (GSK) Biologicals' licensed Hepatitis A vaccine

Indicates status has not been verified in more than two years